Frontiers in Immunology | Multiple Sclerosis and Neuroimmunology

Case Report

Published on 04 Apr 2025

Switching to ublituximab from prior anti-CD20 monoclonal antibody therapy: a case report series

in Multiple Sclerosis and Neuroimmunology

Regina Berkovich
Jonathan Calkwood
Heidi Crayton
April Erwin
Simon Faissner
Ralf Gold
Joshua Katz
Mark Leekoff

Frontiers in Immunology

doi 10.3389/fimmu.2025.1527102

384 views

Mini Review

Published on 02 Apr 2025

The role of NLRP3 inflammasome in multiple sclerosis: pathogenesis and pharmacological application

in Multiple Sclerosis and Neuroimmunology

Wen-Gang Zhang
Xiao-Rui Zheng
Yi Yao
Wei-Jia Sun
Bo-Zong Shao

Frontiers in Immunology

doi 10.3389/fimmu.2025.1572140

285 views

Review

Published on 01 Apr 2025

Roles of METTL3 and NLRP3 in pyroptosis and prospects in SCIRI

in Multiple Sclerosis and Neuroimmunology

Xiaoqing Guan
Fengyi Zhang
Ning Zhang
Guangchun Li
Fei Yin

Frontiers in Immunology

doi 10.3389/fimmu.2025.1552704

158 views

Original Research

Accepted on 31 Mar 2025

The P2X7R-antagonist AFC-5128 ameliorates chronic experimental autoimmune encephalomyelitis in a preventive and therapeutic paradigm

in Multiple Sclerosis and Neuroimmunology

Robert Hoffrogge
Anna Karachunskaya
Neele Heitmann
Xiomara Pedreiturria
Katharina Kloester
Verian Bader
Konstanze F. Winklhofer
Michael Hamacher
Bert Klebl
Ralf Gold

Frontiers in Immunology

doi 10.3389/fimmu.2025.1554999

Original Research

Accepted on 31 Mar 2025

Shared Circulating Diagnostic Biomarkers and Molecular Mechanisms in Ischemic Stroke and Systemic Lupus Erythematosus

in Multiple Sclerosis and Neuroimmunology

Xiaoyi Ma
Lifei Huang
Huanhuan Yan

Frontiers in Immunology

doi 10.3389/fimmu.2025.1565379

Original Research

Accepted on 28 Mar 2025

Serum Angiotensin type-1 receptor autoantibodies and neurofilament light chain as markers of neuroaxonal damage in post-COVID patients

in Multiple Sclerosis and Neuroimmunology

Ana Isabel Rodríguez Pérez
Gemma Serrano-Heras
Carmen Labandeira Guerra
Laura Camacho-Meño
Beatriz Castro Robles
Juan A Suarez-Quintanilla
Monica Munoz-Lopez
Pepa Piqueras-Landete
María J Guerra
Tomás Segura Martín

Frontiers in Immunology

doi 10.3389/fimmu.2025.1571027

114 views

Original Research

Accepted on 25 Mar 2025

Comparison of commercial and in-house tissue-based and cell-based assays for the detection of autoantibodies targeting neuronal surface proteins: a prospective cohort study

in Multiple Sclerosis and Neuroimmunology

David Goncalves
Marie Benaiteau
Veronique Rogemond
Sterenn Closs
Anne-Laurie Pinto
Maroua Dhairi
Marine Villard
Géraldine Picard
Fabien Nicole
Jerome Honnorat

Frontiers in Immunology

doi 10.3389/fimmu.2025.1563877

108 views

Mini Review

Published on 25 Mar 2025

Advocating the role of trained immunity in the pathogenesis of ME/CFS: a mini review

in Multiple Sclerosis and Neuroimmunology

Bart Humer
Willem A. Dik
Marjan A. Versnel

Frontiers in Immunology

doi 10.3389/fimmu.2025.1483764

982 views

Review

Accepted on 24 Mar 2025

Controversies and insights into cytokine regulation of neurogenesis and behavior in adult rodents

in Multiple Sclerosis and Neuroimmunology

Rodrigo-Daniel Sepúlveda-Cuéllar
Diego Alberto Soria-Medina
Irma Cañedo
Fernando Gómez-Chávez
Liliana Monserrat Molina- López
María-Yolanda Cruz-Martínez
Dolores Correa

Frontiers in Immunology

doi 10.3389/fimmu.2025.1550660

Original Research

Published on 24 Mar 2025

Integrated bioinformatics analysis and biological experiments to identify key immune genes in vascular dementia

in Multiple Sclerosis and Neuroimmunology

Yilong Zhao
Wen Xing
Weiqi Chen
Yilong Wang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1560438

322 views

Review

Published on 21 Mar 2025

Current challenges in secondary progressive multiple sclerosis: diagnosis, activity detection and treatment

in Multiple Sclerosis and Neuroimmunology

Luis Brieva
Carmen Calles
Lamberto Landete
Celia Oreja-Guevara

Frontiers in Immunology

doi 10.3389/fimmu.2025.1543649

743 views

Original Research

Accepted on 20 Mar 2025

Worse recovery from acute attacks and faster disability accumulation highlights the unmet need for improved treatment in patients with late-onset neuromyelitis optica spectrum disorders (COPTER-LO study)

in Multiple Sclerosis and Neuroimmunology

Julian Reza Kretschmer
Daria Tkachenko
Tania Kümpfel
Joachim Havla
Daniel Engels
Friedemann Paul
Patrick Schindler
Judith Theresia Bellmann-Strobl
Achim Berthele
Katrin Giglhuber

Frontiers in Immunology

doi 10.3389/fimmu.2025.1575613

203 views

Original Research

Published on 14 Mar 2025

Comparison of the clinical and laboratory characteristics of neuromyelitis optica spectrum disorder with or without cerebrospinal fluid oligoclonal bands: a cohort with 36-month follow-up

in Multiple Sclerosis and Neuroimmunology

Wenbo Yang
Xiaoni Liu
Jie Wei
Hai Yu
Wanqing Wu
Jingguo Wang
Bo Deng
Xiaoqin Wu
Xiangjun Chen
Xiang Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1536853

369 views

Case Report

Published on 14 Mar 2025

Case Report: CASPR2-associated autoimmune encephalitis with NF155 Antibody-positive autoimmune nodopathies: a rare case with hyponatremia onset

in Multiple Sclerosis and Neuroimmunology

Wen-Ya Wang
Jing-Ying Huang
Ying Xue
An-Ran Zhang
Ruo-Yi Guo
Zhen Jia
Ya-Fei Sun
Bin Li

Frontiers in Immunology

doi 10.3389/fimmu.2025.1519878

309 views

Case Report

Published on 11 Mar 2025

Case Report: Ofatumumab treatment for concomitant multiple sclerosis and idiopathic thrombocytopenic purpura

in Multiple Sclerosis and Neuroimmunology

Yuki Yokota
Makoto Hara
Hideto Nakajima

Frontiers in Immunology

doi 10.3389/fimmu.2025.1515776

972 views

Original Research

Published on 05 Mar 2025

Positive allosteric modulation of AMPA receptors via PF4778574 leads to reduced demyelination and clinical disability in experimental models of multiple sclerosis

in Multiple Sclerosis and Neuroimmunology

Mustafa Sindi
Michael Dietrich
Diana Klees
Joel Gruchot
Christina Hecker
John Silbereis
Andrea Issberner
Hans-Peter Hartung
Tobias Ruck
Holger Stark

Frontiers in Immunology

doi 10.3389/fimmu.2025.1532877

829 views